These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Enzyme inhibition as a possible cause of secondary increases in metabolite levels in patients with inborn errors of metabolism. Palmer T; Ameen M J Inherit Metab Dis; 1980; 3(3):79-80. PubMed ID: 6775141 [No Abstract] [Full Text] [Related]
12. [A case of citrullinemia with cluster type distribution of argininosuccinate synthetase in the liver]. Ikeda M; Orimo S; Kurosawa T; Arai M; Hiyamuta E Rinsho Shinkeigaku; 1987 Jul; 27(7):931-5. PubMed ID: 3665284 [No Abstract] [Full Text] [Related]
13. Citrullinemia: quantitative deficiency of argininosuccinate synthetase in the liver. Oyanagi K; Itakura Y; Tsuchiyama A; Nakao T; Nakano K; Saeki T Tohoku J Exp Med; 1986 Apr; 148(4):385-91. PubMed ID: 3738904 [TBL] [Abstract][Full Text] [Related]
14. The human argininosuccinate synthetase locus and citrullinemia. Beaudet AL; O'Brien WE; Bock HG; Freytag SO; Su TS Adv Hum Genet; 1986; 15():161-96, 291-2. PubMed ID: 3513483 [No Abstract] [Full Text] [Related]
15. Prospective management of a child with neonatal citrullinemia. Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623 [TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. Saheki T; Ueda A; Hosoya M; Kusumi K; Takada S; Tsuda M; Katsunuma T Clin Chim Acta; 1981 Feb; 109(3):325-35. PubMed ID: 6784969 [TBL] [Abstract][Full Text] [Related]